Weight-loss injections sold online: warning signs to recognise
Injectable slimming products on social media: spot dubious claims, unclear supply chains and false guarantees.
Blog — nutrition, keto and healthy eating
Hardly hungry while taking GLP-1 medication: how can you keep eating well?
Reduced appetite whilst on GLP-1: small portions, staying hydrated and planning meals to ensure nutritional needs are met without feeling forced.
Mounjaro and heart health: what the new US approval changes
Mounjaro and cardiovascular risk: understanding the new US indication, the results of the SURPASS-CVOT trial and their limitations.
Retatrutide: what the new phase 3 results really show
Retatrutide in 2026: study populations, phase 3 results, adverse effects and limitations of a treatment that is still experimental.
GLP-1 tablets: can you now lose weight without injections?
GLP-1 tablets: US approvals, differences compared to injections, and questions to ask before considering treatment in Morocco.
Stopping a GLP-1: why weight may return and how to prepare for the aftermath
Weight regain after treatment with semaglutide or tirzepatide is common. Understanding the mechanism helps you plan ahead with your doctor.
GLP –1 and muscle mass: lose fat without sacrificing strength
Protein, weight training, weight loss rate and monitoring: the priorities for maintaining lean body mass whilst on GLP-1 treatment.
Ozempic, Wegovy, Mounjaro, orforglipron and retatrutide: an update on 2026
Semaglutide, tirzepatide, oral GLP-1e and retatrutide: mechanisms of action, indications, results, risks and regulatory status as of August 2026.